Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus–Associated Oropharyngeal Cancer

MLA

Cramer, John D., et al. “Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus–Associated Oropharyngeal Cancer.” JAMA Otolaryngology - Head & Neck Surgery, vol. 145, no. 12, Dec. 2019, pp. 1105–14. EBSCOhost, https://doi.org/10.1001/jamaoto.2019.0820.

APA

Cramer, J. D., Dundar, Y., Hotaling, J., Raza, S. N., & Lin, H.-S. (2019). Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus–Associated Oropharyngeal Cancer. JAMA Otolaryngology - Head & Neck Surgery, 145(12), 1105–1114. https://doi.org/10.1001/jamaoto.2019.0820

Chicago

Cramer, John D., Yusuf Dundar, Jeffrey Hotaling, S. Naweed Raza, and Ho-Sheng Lin. 2019. “Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus–Associated Oropharyngeal Cancer.” JAMA Otolaryngology - Head & Neck Surgery 145 (12): 1105–14. doi:10.1001/jamaoto.2019.0820.